Pneumococcal Vaccine for Infants and Toddlers
Links shared publicly online about this topic
PNEUMOCOCCAL VACCINE FOR INFANTS AND TODDLERS
rogerknapp.com — “PNEUMOCOCCAL VACCINE FOR INFANTS AND TODDLERS Roger Knapp pediatrician medical advice and information.” View full resource at rogerknapp.com
Most Recently Shared on September 30, 2010 at 9:13 pm By:
Just added http://bit.ly/azr1EO to the Pneumococcal Vaccine for Infants and Toddlers WisdomCard http://bit.ly/aqb8Yk @organizedwisdom
Pneumococcal conjugate vaccine appears to reduce pneumonia, serious complications in infants: Research
news-medical.net — “A pneumococcal conjugate vaccine introduced in the U.S. 10 years ago appears to reduce pneumonia and serious associated complications, such as blood infections, in the vaccine's target range, children less than a year old, according to new research.” View full resource at news-medical.net
Most Recently Shared on July 19, 2010 at 5:43 am By:
Pneumococcal conjugate vaccine appears to reduce pneumonia, serious complications in infants: Research: A pneumoco... http://bit.ly/ddBw0c
FDA Approves Pneumococcal Disease Vaccine with Broader Protection
fda.gov — “The U.S. Food and Drug Administration today approved Prevnar 13, a pneumococcal 13-valent conjugate vaccine for infants and young children ages 6 weeks through 5 years. Prevnar 13 will be the successor to Prevnar, the pneumococcal 7-valent conjugate vaccine licensed by the FDA in 2000 to prevent invasive pneumococcal disease (IPD) and otitis media. The new vaccine extends the protection to six additional types of the disease causing bacteria.” View full resource at fda.gov
Most Recently Shared on February 24, 2010 at 6:31 pm By:
Len Leshin Physician, Doctor, and Pediatrician
FDA approves new #Pneumococcal Vaccine with Broader Protection for infants, toddlers http://bit.ly/9as7JB #pediatrics #Prevnar
Pneumococcal vaccine has cut disease among Navajos | Reuters
reuters.com — “NEW YORK (Reuters Health) - The infant pneumococcal vaccine introduced 10 years ago has cut rates of pneumonia, meningitis and other infections among Navajos in the U.S. -- but their risks remain higher” View full resource at reuters.com
Most Recently Shared on April 22, 2010 at 6:03 pm By:
HealthIT Policy Health News and Health IT
Pneumococcal vaccine has cut disease among Navajos: NEW YORK (Reuters Health) - The infant pneumococcal vaccine in... http://bit.ly/9bs9yK
Pneumococcal vaccine has cut disease among Navajos | Reuters
reuters.com — “NEW YORK (Reuters Health) - The infant pneumococcal vaccine introduced 10 years ago has cut rates of pneumonia, meningitis and other infections among Navajos in the U.S. -- but their risks remain higher” View full resource at reuters.com
Most Recently Shared on April 22, 2010 at 6:06 pm By:
Pneumococcal vaccine has cut disease among Navajos http://link.reuters.com/weg98j
Pfizer to supply pneumococcal conjugate vaccines for infants and children
news-medical.net — “Pfizer Inc. today announced it has signed a 10-year Provisional Supply Agreement to supply Prevenar 13* (Pneumococcal Polysaccharide Conjugate Vaccine [13-valent, adsorbed]), the company's 13-valent pneumococcal conjugate vaccine, for infants and young children in the world's poorest countries under the terms of the Advance Market Commitment (AMC) pilot project against pneumococcal disease.” View full resource at news-medical.net
Most Recently Shared on March 24, 2010 at 5:16 pm By:
Meningitis News: Pfizer to supply pneumococcal conjugate vaccines for infants and children: Pfizer Inc. today anno... http://bit.ly/coSs8Q
Pediatrics Article | Pneumococcal Vaccines
mdlinx.com — “Responses to a Conjugate Pneumococcal Vaccine in Preterm Infants Immunized at 2, 3, and 4 Months of Age” View full resource at mdlinx.com
Most Recently Shared on November 6, 2010 at 11:41 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Responses to a Conjugate Pneumococcal Vaccine in Preterm Infants Immunized at 2, 3, and 4 Months of Age: C... http://bit.ly/biGZoT #peds
Pfizer's Prevenar pneumococcal 13-valent conjugate vaccine receives WHO prequalification
news-medical.net — “The World Health Organization (WHO) has granted prequalification to Prevenar 13 (Pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed])for active immunization of infants and children from 6 weeks through five years of age against invasive disease, pneumonia and otitis media caused by the 13 pneumococcal serotypes (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F) contained in the vaccine.” View full resource at news-medical.net
Most Recently Shared on August 24, 2010 at 5:13 am By:
Pfizer's Prevenar pneumococcal 13-valent conjugate vaccine receives WHO prequalification: The World Health Organiz... http://bit.ly/c8uCg5
Providing Long-Term Affordable Supply Of Pneumococcal Vaccines To The World's Poorest Children
medicalnewstoday.com — “Millions of infants and young children in the world's poorest countries will receive potentially life-saving vaccines that help protect against pneumococcal disease, including pneumonia - the worl” View full resource at medicalnewstoday.com
Most Recently Shared on March 25, 2010 at 12:19 pm By:
Providing Long-Term Affordable Supply Of Pneumococcal Vaccines To The World's Poorest Children http://mnt.to/3zps #asthma
Infectious Disease Article | Pneumococcal Vaccines
mdlinx.com — “Responses to a Conjugate Pneumococcal Vaccine in Preterm Infants Immunized at 2, 3, and 4 Months of Age” View full resource at mdlinx.com
Most Recently Shared on November 7, 2010 at 5:22 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Responses to a Conjugate Pneumococcal Vaccine in Preterm Infants Immunized at 2, 3, and 4 Months of Age: Cli... http://bit.ly/9iuTQM #ID
Pharmaceutical firms, GAVI Alliance agree to provide long-term supply of Pneumococcal vaccine
news-medical.net — “Millions of infants and young children in the world's poorest countries will receive potentially life-saving vaccines that help protect against pneumococcal disease, including pneumonia -- the world's biggest childhood killer, thanks to new agreements made with two major pharmaceutical firms, the GAVI Alliance announced today.” View full resource at news-medical.net
Most Recently Shared on March 24, 2010 at 10:58 am By:
Pharmaceutical firms, GAVI Alliance agree to provide long-term supply of Pneumococcal vaccine: Millions of infants... http://bit.ly/9uOlB0
Prevention of Pneumococcal Disease Among Infants and Children --- Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine
cdc.gov — “Prevention of Pneumococcal Disease Among Infants and Children --- Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine” View full resource at cdc.gov
Most Recently Shared on December 10, 2010 at 2:52 pm By:
HealthTrendster Health Executive
RECOMMENDATIONS AND REPORTS: Prevention of Pneumococcal Disease Among Infants and Children… http://goo.gl/fb/p6HR3
FDA approves meningococcal vaccine for infants and toddlers
pediatricsupersite.com — “The FDA has approved a vaccine for the prevention of invasive meningococcal disease caused by certain serogroups of Neisseria meningitidis for u” View full resource at pediatricsupersite.com
Most Recently Shared on April 25, 2011 at 3:25 pm By:
Pediatric SuperSite Health Site
FDA approves meningococcal vaccine for infants and toddlers http://ow.ly/4GpzI
World's poorest children among first to receive new life-saving pneumococcal vaccines
physorg.com — “Millions of infants and young children in the world's poorest countries will receive potentially life-saving vaccines that help protect against pneumococcal disease, including pneumonia -- the world's biggest childhood killer, thanks to new agreements made with two major pharmaceutical firms, the GAVI ...” View full resource at physorg.com
Most Recently Shared on March 23, 2010 at 8:00 pm By:
PhysOrg Health News Health News
World's poorest children among first to receive new life-saving pneumococcal vaccines http://tw.physorg.com/188577494
Symposier - New Pneumococcal Vaccine for Children
symposier.com — “Uploaded and Shared in Youtube by: USFoodandDrugAdmin FDA has approved a new pneumococcal vaccine that provides broader protection for infants and young children ages six weeks through five years. The new vaccine, called Prevnar 13, is effective against 13 serotypes of the bacterium Streptococcus pneumoniae. It will replace Prevnar, which was effective against seven serotypes. Prevnar 13 is approved to prevent invasive pneumococcal disease, including bacterial meningitis and bacteremia, caused b” View full resource at symposier.com
Most Recently Shared on May 21, 2010 at 6:04 pm By:
FDA - New Pneumococcal Vaccine for Children. http://bit.ly/cML6lF
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Susan S
Mom working in health content publishing field. Enjoy sharing information for healthy living.
-
News-Medical.Net
Medical News from Around the World
-
Len Leshin
Husband, father to two boys, one with Down syndrome. Practicing pediatrician.
Advertisement
